Will work for 10 years: scientists have developed a universal vaccine against all forms of influenza.

New universal flu vaccine

Scientists from the University of Nebraska-Lincoln (USA) have created a revolutionary vaccine called Epigraph, capable of protecting against numerous strains of influenza A, including those dangerous to humans, pigs, and birds. The development, led by virologist Eric Weaver, is based on computer analysis of over 6,000 virus variants.

Annual flu vaccinations may become a thing of the past thanks to a new vaccination strategy developed and tested by virologist Eric Weaver and his team from the University of Nebraska.

Testing over a six-month period confirmed a long-lasting immunity, estimated to last up to ten years. The vaccine effectively neutralized 12 strains, including the pandemic H1N1 of 2009.

This research lays the groundwork for the development of universal flu vaccines, so that people will not have to get annual vaccinations.

Epigraph outperforms commercial analogs and reduces the risk of virus transmission between animals and humans. The next stages of research will include testing on H1 and H3 strains, which could potentially reduce the prevalence of influenza worldwide.

An important advantage of the vaccine is its stability for storage without special conditions, simplifying logistics. This development could be a breakthrough in flu prevention, eliminating the need for annual revaccination and reducing the global burden of the disease.